A Study to Compare the Efficacy of Low Dose Magnesium Sulphate (dhaka) Regime with Pritchard Regime in Eclampsia

Background: Eclampsia is a hypertensive disorder related to pregnancy, in which there is occurrence of one or more generalized convulsions and or coma, in the absence of other neurologic conditions. It is a common obstetric emergency. Eclampsia is associated with elevated maternal and fetal morbidity and mortality. Objectives: To compare the efficacy of low dose magnesium sulphate (Dhaka) regime with Pritchard regime in Eclampsia. Material and Methods: A prospective randomized study of fifty eclampsia cases, treated with magnesium sulphate (25 each from low dose magnesium sulphate (Dhaka) regime and Pritchard regime) was carried out for one year i.e. January 2010 to December 2010 at Pravara Rural Hospital, Loni. Results were analysed using Statistical Package of Social Sciences (SPSS) 13.0. Results: In the present study, convulsions were controlled in 88% of eclampsia cases with low dose magnesium sulphate (Dhaka) regime. Two cases i.e. 8% had single episode of recurrence of convulsion, which was controlled by giving additional 2 grams of 20% magnesium sulphate intravenous single dose. Perinatal mortality in low dose magnesium sulphate (Dhaka) regime was lesser (24%) than Pritchard regime (32%). Conclusion: Low dose magnesium sulphate (Dhaka) regime was equally effective as Pritchard regime in control of eclamptic convulsions. There was no magnesium related toxicity with low dose magnesium sulphate (Dhaka) regime. Maternal and perinatal outcome was better in low dose magnesium sulphate (Dhaka) regime as compared to Pritchard regime.